Trial intelligence / Profile preview

Liraglutide Kidney

2012-003577-26Phase 4Completed

Sponsor
Aarhus University Hospital
Start
Sep 2012
Modality
Peptides
Countries
1
01

Overview

Phase 4, single-arm trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Aarhus University Hospital. Primary endpoint: Impact of single-dose liraglutide on glomerular filtration rate. Started Sep 2012; status: completed.

02

Drugs

03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2012-003577-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003577-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call